Capital Com MENA Securities Trading LLC is regulated by the Capital Market Authority.
Open platformOpen platform

Perrigo to sell infant formula business to MeridianMade for up to $175 million

By Reuters News

Oct 29 (Reuters) - Perrigo PRGO.N said on Thursday that it will sell its infant formula business to privately held contract manufacturing firm MeridianMade for up to $175 million, as the consumer health products company sharpens its focus on over-the-counter medicines and self-care products.


Here are some details:

  • The transaction follows a strategic review of the infant formula business by Perrigo last year

  • The deal includes $40 million in cash at closing and as much as $135 million in additional payments tied to business's performance through 2030

  • Perrigo expects the transaction to close in the first half of 2027

  • MeridianMade CEO Ron Belldegrun and President Mia Funt previously co-founded ByHeart, an infant formula brand that recalled its products nationwide after reports of infant botulism

  • Earlier this month, Perrigo agreed to pay $10 million to settle a US class action. The suit accused it of conspiring with Gerber Products to keep new competitors out of the store-brand infant formula market, which allegedly allowed Perrigo to raise prices that retailers passed on to consumers

  • Last week, Abbott ABT.N announced that it is separating its nutrition business, which includes baby formulas

  • Perrigo's infant formula unit has faced scrutiny over manufacturing quality and contamination risks


Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.